Nanobeads (column-based positive selection) · Catalogue PM480
F4/80 (also EMR1 or Ly71) is a 160 kD glycoprotein of the EGF-TM7 family and the standard lineage marker for mouse tissue-resident macrophages: lung, intestine, peritoneal cavity, thymus and splenic red-pulp macrophages, Kupffer cells, Langerhans cells, microglia and some dendritic cells. Macrophages in the splenic T-cell zone, lymph nodes and Peyer's patches do not express it. The natural ligand is unknown; F4/80 has been implicated in CD8⁺ T-cell-mediated peripheral tolerance.
Anti-mouse F4/80 antibody is conjugated directly to ~50 nm nanobeads. In a column-based magnetic field labelled cells are retained and the rest flow through, so the same protocol serves both enrichment and depletion of F4/80⁺ cells.
| Catalogue | Size | List price | Promo price | Manual | COA |
|---|---|---|---|---|---|
| PM480L | 2 mL, for 2e+9 cells | ¥4000 | ¥3200 | Search | |
| PM480M | 1 mL, for 1e+9 cells | ¥2500 | ¥2000 | Search | |
| PM480S | 0.2 mL, for 2e+8 cells | ¥700 | ¥560 | Search |
| Target | F4/80 (EMR1 / Ly71 / ADGRE1), 160 kD, EGF-TM7 family |
|---|---|
| Expressed on | Tissue-resident macrophages (lung, intestine, peritoneum, thymus, splenic red pulp), Kupffer cells, Langerhans cells, microglia, some dendritic cells |
| Not expressed on | Macrophages in the splenic T-cell zone, lymph nodes and Peyer's patches |
| Antibody / buffer | Anti-mouse F4/80 conjugated to nanobeads; PBS with 0.1% BSA |
| Storage | 4 °C. Do not freeze. |
| Recommended dose | 10 µL per 1×10⁷ cells for samples with <20% F4/80⁺ cells (e.g. mouse spleen) |
| Incubation | 4 °C, 10 min |
| Columns | M column (M1/M8 magnet) or L column (L1/L4 magnet) |
| Manual version | v26.02 |
Mouse spleen single-cell suspension was labelled with 10 µL of anti-mouse F4/80 Nanobeads per 1×10⁷ cells, incubated at 4 °C for 10 min and separated once on a column. F4/80 was detected with a FITC-conjugated antibody before and after separation.
| Readout | Before | After |
|---|---|---|
| F4/80⁺ in the positive fraction | 3.26% | 71.6% (~22-fold enrichment) |
| F4/80⁺ remaining in the flow-through | — | 0.68% |
Single run shown in manual v26.02; no cell counts were taken, so yield and recovery are not calculated. For samples with a low starting frequency, repeat loading and elution on a fresh column (manual step 11) to raise purity.
| F4/80⁺ frequency | Sample | Cell density | Bead dose |
|---|---|---|---|
| <20% | Mouse spleen | 1×10⁸ cells/mL | 10 µL per 1×10⁷ cells |
| 20–50% | Processed samples | 1×10⁸ cells/mL | 15 µL per 1×10⁷ cells |
| >50% | Ascites and similar | 1×10⁸ cells/mL | 20 µL per 1×10⁷ cells |
Bubbles usually come from protein-containing buffer. Fill the column with 3 mL of FACS buffer before pushing the cells out, and press the plunger once — do not pump repeatedly. If bubbles persist, switch to a high-quality PBS for the elution step.
No. Separation columns are single-use. Reuse reduces recovery and purity and carries a cross-contamination risk.
Retention is low when the labelling density and column load follow the manual. If purity is the priority for a low-abundance population, repeat the separation with a fresh column rather than washing the first one repeatedly.
CD45 marks all nucleated hematopoietic cells (leukocytes) — lymphocytes, monocytes, macrophages, granulocytes and dendritic cells. Mature red blood cells and platelets are CD45-negative. CD45 is therefore a pan-leukocyte marker, not a synonym for every immune cell type.
They are validated on PBMC, spleen, lymph node and bone marrow. Solid-tissue samples need proper dissociation and red-cell lysis first; recovery will depend on how well the single-cell suspension is prepared.
Each kit states a cell-number capacity (for example 1×10⁹ cells) rather than a sample count, because sample size varies. Divide your total cell number by that capacity to estimate how many experiments one kit supports.
Cell frequencies differ between strains and with age, which changes the starting purity but not the workflow. Record strain, age and sex so results stay comparable across experiments.
In human PBMC, T cells are roughly 45–70%, B cells 5–15%, NK cells 5–20% and monocytes 10–30%. In mouse spleen, B cells are around 45–55% and T cells around 30–40%. Treat these as typical ranges, not constants.
FACS buffer (PBS with 0.02% EDTA and 2% FBS) supplies protein to block non-specific binding and EDTA to prevent cell clumping. Using plain PBS lowers recovery and viability.
Nanobeads (about 50 nm) bind the target antigen and are retained in a magnetic field. They occupy only about 20–30% of the antigen epitopes, do not interfere with flow-cytometry staining and require no specific antibody clone. Because they are biodegradable and do not activate the cells, no removal step is required for most downstream assays.
Mouse spleen: B cells about 45–55%, T cells about 30–40%, and much smaller NK, DC and macrophage populations. Mouse bone marrow: CD117⁺ progenitors about 10–30%. Frequencies shift with strain and immune status.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.